Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Impairment of hepatic transport processes in perfused rat liver by the specific CCK receptor antagonist loxiglumide.

Impairment of hepatic transport processes in perfused rat liver by the specific CCK receptor antagonist loxiglumide. Res Exp Med (Berl). 1997; 197(3):125-35.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.